Relmada Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
31 Jan 24 | Buy€139,103 | Charles Ence | Individual | 38,970 | €3.74 | |
31 Jan 24 | Buy€115,873 | Maged Shenouda | Individual | 32,675 | €3.75 | |
31 Jan 24 | Buy€356,456 | Sergio Traversa | Individual | 100,000 | €3.68 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,756 | 0.0323% |
Individual Insiders | 2,415,243 | 8% |
General Public | 12,540,111 | 41.6% |
Institutions | 15,209,092 | 50.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,899,930 | €5.3m | 0% | no data | |||
1,256,705 | €3.5m | -4.13% | no data | |||
1,240,034 | €3.5m | -39.4% | 0.11% | |||
1,200,000 | €3.3m | 943% | 0.32% | |||
1,181,186 | €3.3m | -0.14% | 0.01% | |||
973,520 | €2.7m | 2.49% | 0.2% | |||
862,279 | €2.4m | 0% | 5.03% | |||
759,000 | €2.1m | -13.5% | 0.56% | |||
732,400 | €2.0m | 0% | 0.21% | |||
630,251 | €1.8m | 0% | no data | |||
578,188 | €1.6m | 0.95% | no data | |||
341,450 | €951.8k | 71.7% | no data | |||
326,200 | €909.3k | -0.64% | no data | |||
256,087 | €713.9k | 5.21% | no data | |||
244,024 | €680.2k | 69.4% | no data | |||
227,039 | €632.9k | -25% | no data | |||
224,846 | €626.8k | 0% | no data | |||
210,576 | €587.0k | -0.03% | no data | |||
207,870 | €579.5k | 35.4% | no data | |||
195,777 | €545.7k | 15.1% | 0.01% | |||
191,000 | €532.4k | -9.95% | 0.7% | |||
187,295 | €522.1k | 0% | no data | |||
184,338 | €513.9k | 16.4% | 0.02% | |||
175,978 | €490.6k | 836% | no data | |||
175,229 | €488.5k | 1,340% | no data |